Search results for "harm"

showing 10 items of 13866 documents

Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial

2014

SummaryBackground A phase I dose-escalation trial of transarterial chemoembolisation (TACE) with idarubicin-loaded beads was performed in cirrhotic patients with hepatocellular carcinoma (HCC). Aim To estimate the maximum-tolerated dose (MTD) and to assess safety, efficacy, pharmacokinetics and quality of life. Methods Patients received a single TACE session with injection of 2 mL drug-eluting beads (DEBs; DC Bead 300–500 μm) loaded with idarubicin. The idarubicin dose was escalated according to a modified continuous reassessment method. MTD was defined as the dose level closest to that causing dose-limiting toxicity (DLT) in 20% of patients. Results Twenty-one patients were enrolled, inclu…

medicine.medical_specialtyHepatologybusiness.industryGastroenterologymedicine.diseaseGastroenterologyPharmacokinetic analysisSurgeryPharmacokineticsInternal medicineHepatocellular carcinomaToxicitymedicineIdarubicinPharmacology (medical)Myocardial infarctionbusinessAdverse effectObjective responsemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors’ reply

2012

medicine.medical_specialtyHepatologybusiness.industryGeneral surgeryGastroenterologymedicine.diseaseGastroenterologyInternal medicineHepatocellular carcinomahepatocellular carcinoma transarterial chemoembolisationmedicinePharmacology (medical)Liver dysfunctionbusinessAlimentary Pharmacology & Therapeutics
researchProduct

Visceral adiposity index and exercise in non-alcoholic fatty liver disease: authors’ reply

2012

We thank Prof. Filik for his interest in our recent article. 2 He points to the fact that the interpretation of our results could be affected by lack of data on physical activity and diet. In response to this issue, we are aware that both physical activity and diet are able to affect not only anthropometric and metabolic parameters of visceral adiposity index (VAI) but also the severity of liver disease. Unfortunately, data on both physical activity and diet in our patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD) are not available, even if we are confident that their variations should not significantly affect our results. In fact, in our study, we evaluated histological…

medicine.medical_specialtyHepatologybusiness.industrySurrogate endpointFatty liverGastroenterologyNon alcoholicDiseaseAnthropometrymedicine.diseaseGastroenterologyLiver diseaseEndocrinologyInternal medicineMedicinePharmacology (medical)Liver damagebusinessMETABOLIC FEATURESAlimentary Pharmacology & Therapeutics
researchProduct

Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease

2010

Aliment Pharmacol Ther 2011; 33: 358–365 Summary Background  Ulcerative colitis with diverticulosis (UCD), segmental colitis associated with diverticulosis (SCAD) and acute uncomplicated diverticulitis (AUD) may affect the same colonic regions, but the real incidence of these entities in clinical practice is unknown. Aim  To assess the incidence and the endoscopic findings of UCD, SCAD and AUD. Methods  From January 2004 to June 2009, 8525 consecutive colonoscopies were performed. Diagnosis of the diseases was based on specific endoscopic and histological (UCD and SCAD), and on endoscopic and radiological (AUD) patterns. Results  Ulcerative colitis with diverticulosis was diagnosed in 25 pa…

medicine.medical_specialtyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyDiverticulitismedicine.diseaseUlcerative colitisGastroenterologydigestive system diseasesDiverticulosisEndoscopyInternal medicinemedicinePharmacology (medical)Differential diagnosisColitisProspective cohort studybusinessAlimentary Pharmacology & Therapeutics
researchProduct

Habenular effect on hippocampal excitability is not cholinergically-mediated.

1989

medicine.medical_specialtyHippocampusStimulationHippocampal formationHippocampusParasympathetic Nervous SystemInternal medicinemedicineAnimalsPharmacologybiologyIontophoresisChemistryFissipediabiology.organism_classificationElectric StimulationCochleaEndocrinologyHabenulaMechanism of actionCatsRaphe Nucleimedicine.symptomNeuroscienceAcetylcholinemedicine.drugPharmacological research
researchProduct

<i>PCSK9</i> rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD

2020

Background and Aims: The proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in cholesterol homeostasis, and its inhibition represents an effective therapy to lower LDL-C levels. In this study, we examined the impact of PCSK9 rs11591147 loss-of-function (LOF) variant on liver damage in a multicenter collection of patients at risk of nonalcoholic steatohepatitis (NASH), in clinical samples and experimental models. Methods: We considered 1,874 consecutive individuals at risk of NASH as determined by histology. The SNP rs11591147, encoding for the p.R46L variant of PCSK9, was genotyped by TaqMan assays. We also evaluated 1) PCSK9 mRNA hepatic expression in human liver, and 2…

medicine.medical_specialtyHuman liverbusiness.industryPCSK9Helsinki declarationFat accumulationInformed consentInternal medicineMedicinemedia_common.cataloged_instanceLiver damageEuropean unionbusinessPharmacogeneticsmedia_commonSSRN Electronic Journal
researchProduct

Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model.

2011

Abstract Transport across the blood–brain barrier is a relevant factor in the pharmacological action of many drugs and endogenous substances whose action site is located in brain. An overactive P-gp has been suggested to be of relevance for the resistance of the HPA system to be suppressed by glucocorticoids, which is one of the best described biological abnormalities in certain types of depression. PUFA acids have shown clinical efficacy in depressed patients and the hypothesis is that these compounds are able to reduce HPA axis activity as this effect has been shown in animal models of depression. The objective of the present work was (1) to characterize Cortisol transport through MDCK an…

medicine.medical_specialtyHydrocortisonePharmaceutical ScienceEndogenyBiologyIn Vitro TechniquesBlood–brain barrierModels BiologicalPermeabilityCell LineDogsInternal medicineAnimal models of depressionmedicineAnimalschemistry.chemical_classificationTight junctionTransporterFlow CytometryIn vitromedicine.anatomical_structureEndocrinologychemistryBlood-Brain BarrierFatty Acids UnsaturatedEffluxPolyunsaturated fatty acidEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Therapeutical approach to plasma homocysteine and cardiovascular risk reduction

2008

Marcello Ciaccio, Giulia Bivona, Chiara BelliaDepartment of Medical Biotechnologies and Forensic Medicine, Faculty of Medicine, University of Palermo, ItalyAbstract: Homocysteine is a sulfur-containing aminoacid produced during metabolism of methionine. Since 1969 the relationship between altered homocysteine metabolism and both coronary and peripheral atherotrombosis is known; in recent years experimental evidences have shown that elevated plasma levels of homocysteine are associated with an increased risk of atherosclerosis and cardiovascular ischemic events. Several mechanisms by which elevated homocysteine impairs vascular function have been proposed, including impairment of endothelial…

medicine.medical_specialtyHyperhomocysteinemiaHomocysteineReviewRM1-950folatehomocysteine MTHFR cardiovascular disease folate B vitaminchemistry.chemical_compoundcardiovascular diseaseInternal medicineMedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsEndothelial dysfunctionchemistry.chemical_classificationReactive oxygen speciesChemical Health and SafetyMethioninebiologybusiness.industryhomocysteineGeneral MedicineMetabolismmedicine.diseaseB vitaminB vitaminsEndocrinologychemistryMethylenetetrahydrofolate reductaseMTHFRbiology.proteinTherapeutics. PharmacologybusinessSafety ResearchTherapeutics and Clinical Risk Management
researchProduct

Muscarinic Receptor Activation Increases Efflux of Choline from Isolated Heart and Rat Cortex in Vivo. Interactions with Forskolin and IBMX

1986

Muscarinic receptor activation modulates functions of the heart and neurotransmission in the peripheral and central nervous system. Moreover, muscarinic agonists produce changes in the metabolism of, for example, heart tissue, such as inhibition of beta-adrenoceptor-mediated cAMP accumulation, glycogenolysis and lipase activation.

medicine.medical_specialtyIBMXGlycogenolysisForskolinCentral nervous systemMuscarinic acetylcholine receptor M2NeurotransmissionPharmacologychemistry.chemical_compoundEndocrinologymedicine.anatomical_structurechemistryInternal medicineMuscarinic acetylcholine receptormedicineCholine
researchProduct

Pharmacotherapy of panic attacks.

1988

medicine.medical_specialtyImipraminebusiness.industryPsychopharmacologyPanicGeneral MedicineFearPanicPsychiatry and Mental healthPharmacotherapymedicineHumansPharmacology (medical)medicine.symptomPsychiatrybusinessPharmacopsychiatry
researchProduct